Achillion Pharma (ACHN), Gilead (GILD) Decline; Biotech Pressured
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Join SI Premium – FREE
Achillion Pharma (NASDAQ: ACHN) pared recent gains Friday, as biotech stocks came under pressure. Other decliners included Gilead Sciences (NASDAQ: GILD), and to a lesser extent Biogen Idec (NASDAQ: BIIB) and Pharmacyclics Inc. (Nasdaw: PCYC).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing and Bell Boeing receive defense contracts totaling $56.4M
- SK Hynix's Solidigm eyes 2027 IPO at value up to $150 billion - Reuters
- Trump: Scott Bessent will not be going to be super intelligence (SI) czar
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
